Cargando…

ROS-responsive dimeric prodrug-based nanomedicine targeted therapy for gastric cancer

Gastric cancer (GC) remains a major public health problem. Ursolic acid (UA) is reported to be effective in inhibiting GC; however, its low solubility and poor biocompatibility have greatly hindered its clinical application. Herein, an innovative reactive oxygen species (ROS)-sensitive UA dimeric pr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ma, Jiachi, Chen, Yuzhong, Liang, Wanqing, Li, Lei, Du, Jun, Pan, Chengwu, Zhang, Chensong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8218932/ https://www.ncbi.nlm.nih.gov/pubmed/34142633 http://dx.doi.org/10.1080/10717544.2021.1937380

Ejemplares similares

ω-3 and ω-6 Polyunsaturated Fatty Acids Regulate the Proliferation, Invasion and Angiogenesis of Gastric Cancer Through COX/PGE Signaling Pathway
por: Ma, Jiachi, et al.
Publicado: (2022)

Placenta-specific protein 1 enhances liver metastatic potential and is associated with the PI3K/AKT/NF-κB signaling pathway in colorectal cancer
por: Ma, Jiachi, et al.
Publicado: (2020)

The quantification and clinical analysis of depression and anxiety in patients undergoing Da Vinci robot-assisted radical gastrectomy and open radical gastrectomy
por: Ma, Jiachi, et al.
Publicado: (2020)

Interleukin-1 receptor antagonist inhibits matastatic potential by down-regulating CXCL12/CXCR4 signaling axis in colorectal cancer
por: Ma, Jiachi, et al.
Publicado: (2021)

Engineering Prodrug Nanomedicine for Cancer Immunotherapy
por: Yang, Bin, et al.
Publicado: (2020)

Stimuli-responsive prodrug-based cancer nanomedicine
por: Xie, Angel, et al.
Publicado: (2020)

Combination Therapy of Lung Cancer Using Layer-by-Layer Cisplatin Prodrug and Curcumin Co-Encapsulated Nanomedicine
por: Hong, Yuan, et al.
Publicado: (2020)

Disulfide Bond Bridge Insertion Turns Hydrophobic Anticancer Prodrugs into Self-Assembled Nanomedicines
por: Wang, Yongjun, et al.
Publicado: (2014)

Engineering of small-molecule lipidic prodrugs as novel nanomedicines for enhanced drug delivery
por: Huang, Lingling, et al.
Publicado: (2022)

Nanomedicine in Cancer Targeting and Therapy
por: Palamà, Ilaria Elena, et al.
Publicado: (2022)

Programmed ROS/CO-releasing nanomedicine for synergetic chemodynamic-gas therapy of cancer
por: Zhao, Bin, et al.
Publicado: (2019)

GSH-sensitive polymeric prodrug: Synthesis and loading with photosensitizers as nanoscale chemo-photodynamic anti-cancer nanomedicine
por: Luo, Lei, et al.
Publicado: (2022)

Topical Delivery of ROS-Responsive Methotrexate Prodrug Nanoassemblies by a Dissolvable Microneedle Patch for Psoriasis Therapy
por: Zhou, Yong, et al.
Publicado: (2023)

Editorial: Nanomedicine in Cancer Targeting and Therapy
por: Longo, João Paulo Figueiró, et al.
Publicado: (2021)

Applications of the ROS-Responsive Thioketal Linker for the Production of Smart Nanomedicines
por: Rinaldi, Arianna, et al.
Publicado: (2022)

A Co-delivery System Based on a Dimeric Prodrug and Star-Shaped Polymeric Prodrug Micelles for Drug Delivery
por: Zhou, Man, et al.
Publicado: (2021)

An inorganic prodrug, tellurium nanowires with enhanced ROS generation and GSH depletion for selective cancer therapy
por: Wu, Ying, et al.
Publicado: (2019)

Polymeric Nanoparticles with ROS‐Responsive Prodrug and Platinum Nanozyme for Enhanced Chemophotodynamic Therapy of Colon Cancer
por: Hao, Ying, et al.
Publicado: (2020)

Prodrugs and prodrug-activated systems in gene therapy
por: Sheikh, Semira, et al.
Publicado: (2021)

Enhanced bioreduction-responsive diselenide-based dimeric prodrug nanoparticles for triple negative breast cancer therapy
por: He, Xi, et al.
Publicado: (2018)

Ferroptosis-Inducing Nanomedicine for Cancer Therapy
por: Wang, Yang, et al.
Publicado: (2021)

Polylactide-tethered prodrugs in polymeric nanoparticles as reliable nanomedicines for the efficient eradication of patient-derived hepatocellular carcinoma
por: Wang, Hangxiang, et al.
Publicado: (2018)

Nanomedicine engulfed by macrophages for targeted tumor therapy
por: Li, Siwen, et al.
Publicado: (2016)

Endocytosis and Organelle Targeting of Nanomedicines in Cancer Therapy
por: Wang, Xiaowei, et al.
Publicado: (2020)

Nanomedicine targets iron metabolism for cancer therapy
por: Lin, Liangru, et al.
Publicado: (2022)

Functional Nanomedicines for Targeted Therapy of Bladder Cancer
por: Tang, Chao, et al.
Publicado: (2021)

Bioinspired and Biomimetic Nanomedicines for Targeted Cancer Therapy
por: Xu, Xiaoqiu, et al.
Publicado: (2022)

ROS-responsive chitosan-SS31 prodrug for AKI therapy via rapid distribution in the kidney and long-term retention in the renal tubule
por: Liu, Di, et al.
Publicado: (2020)

Cathepsin B-cleavable doxorubicin prodrugs for targeted cancer therapy
por: ZHONG, YAN-JUN, et al.
Publicado: (2012)

A ROS-responsive polymeric prodrug nanosystem with self-amplified drug release for PSMA (−) prostate cancer specific therapy
por: Wang, Yifan, et al.
Publicado: (2019)

ROS-Activated homodimeric podophyllotoxin nanomedicine with self-accelerating drug release for efficient cancer eradication
por: Liang, Bingfeng, et al.
Publicado: (2021)

Supramolecular Caffeic Acid and Bortezomib Nanomedicine: Prodrug Inducing Reactive Oxygen Species and Inhibiting Cancer Cell Survival
por: Aguilar, Ludwig Erik, et al.
Publicado: (2020)

Prodrugs for Gene-Directed Enzyme-Prodrug Therapy (Suicide Gene Therapy)
por: Denny, William A
Publicado: (2003)

Targeted Delivery of Nanomedicines
por: Kumar Khanna, Vinod
Publicado: (2012)

Targeting assay of a fusion protein applied in enzyme prodrug therapy
por: Wang, Hao, et al.
Publicado: (2017)

Intracellular Reduction-Responsive Molecular Targeted Nanomedicine for Hepatocellular Carcinoma Therapy
por: Ding, Lei, et al.
Publicado: (2022)

Reactive Oxygen Species (ROS)-Responsive Nanomedicine for Solving Ischemia-Reperfusion Injury
por: Chen, Weiyu, et al.
Publicado: (2020)

Reactive Oxygen Species (ROS)-Sensitive Prodrugs of the Tyrosine Kinase Inhibitor Crizotinib
por: Bielec, Bjoern, et al.
Publicado: (2020)

ROS-Responsive and pH-Sensitive Aminothiols Dual-Prodrug for Radiation Enteritis
por: Chen, Yuanfang, et al.
Publicado: (2022)

Cancer Nanomedicine: From Targeted Delivery to Combination Therapy
por: Xu, Xiaoyang, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_dn17so5haf26909nf0uuej12f0